Related news from
Wed, 24 Apr 2024 10:25:00 +0000	Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Tue, 23 Apr 2024 13:29:00 +0000	DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
Tue, 23 Apr 2024 10:14:00 +0000	Boston Scientific, Dexcom and Edwards next as earnings season rolls on J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.
Mon, 22 Apr 2024 13:44:00 +0000	Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings? West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
Mon, 22 Apr 2024 13:16:01 +0000	Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Sun, 21 Apr 2024 12:00:12 +0000	A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW) Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$76.62 With...
Fri, 19 Apr 2024 18:00:00 +0000	Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings? Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.
Fri, 19 Apr 2024 15:30:00 +0000	Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
Fri, 19 Apr 2024 11:46:00 +0000	5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Fri, 19 Apr 2024 11:28:00 +0000	Will High Medical Care Ratios Hurt Molina's (MOH) Q1 Earnings? Molina's (MOH) first-quarter performance is likely to have been hurt by escalating medical care costs, partly offset by growing membership in all three businesses.
Fri, 19 Apr 2024 05:08:25 +0000	Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s After J&J’s $13.1 billion purchase of Shockwave Medical, Moody’s analysts see the potential for other larger pick-ups “if interest rates substantially decrease.”
Thu, 18 Apr 2024 15:14:00 +0000	Will Low Patient Days Impact Community Health (CYH) Q1 Earnings? Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.
Thu, 18 Apr 2024 14:03:00 +0000	Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits? The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
Thu, 18 Apr 2024 14:01:51 +0000	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu, 18 Apr 2024 11:10:00 +0000	Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 IRVINE, Calif., April 18, 2024--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
Wed, 17 Apr 2024 15:01:00 +0000	Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings? The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.
Wed, 17 Apr 2024 15:01:00 +0000	Hologic (HOLX) to Report Q2 Earnings: What's in the Cards? Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
Tue, 16 Apr 2024 18:04:00 +0000	Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings? Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
Tue, 16 Apr 2024 17:25:00 +0000	UnitedHealth Group (UNH) Tops on Q1 Earnings, Reaffirms EPS View UnitedHealth Group (UNH) first-quarter earnings benefit from strong Optum and UnitedHealthcare business lines. Rising expenses partially offset the positives.
Tue, 16 Apr 2024 15:51:00 +0000	Align Technology (ALGN) to Post Q1 Earnings: What's in Store? Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.